Working together to ensure the best treatment for you
ImmunoGenetics has long-standing relationships with biotechnology companies that are pioneering the way today’s cancer is treated.
Thousands of biological processes within the cancer cell affect how each patient responds to treatment. ImmunoGenetics and its network of associates pinpoints the most promising treatment options for your unique cancer.
Foundation Medicine’s tests help to identify the genomic alterations driving a patient’s cancer and match them with relevant targeted therapies, immunotherapies, and clinical trial options. →
Scientists at Nagourney Cancer Institute analyze your living cancer cells to determine the drugs, combinations, and sequences that are most effective and least toxic for treating your cancer. →
Weisenthal Cancer Group provides chemosensitivity and chemoresistance testing of your living cancer cells, which detects the drugs and drug combinations that are most effective at killing your cancer. →